Impact of bleeding on subsequent early and late mortality after drug-eluting stent implantation

JACC: Cardiovascular Interventions

Volumn 4, Issue 4, 2011, Pages 423-431

  Kim, Young Hak ^a   Lee, Jong Young ^a   Ahn, Jung Min ^a   Song, Haegeun ^a   Kim, Won Jang ^a   Yun, Sung Cheol ^a   Park, Duk Woo ^a   Kang, Soo Jin ^a   Lee, Seung Whan ^a   Whan Lee, Cheol ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

bleeding; mortality; myocardial infarction; stent

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGE; ARTICLE; BLEEDING; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SEX DIFFERENCE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955104192     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.12.008     Document Type: Article

References (25)

1. F.G. Kushner, M. Hand, and S.C. Smith Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention J Am Coll Cardiol 54 2009 2205 2241
2. S. Yusuf, F. Zhao, and S.R. Mehta The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial I Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
3. R. Mehran, S.J. Pocock, and G.W. Stone Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with nonST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 2009 1457 1466
4. F.A. Spencer, M. Moscucci, and C.B. Granger Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2007 2793 2801 (Pubitemid 350291221)
5. S.J. Pocock, R. Mehran, and T.C. Clayton Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications Assessment from the Acute Catheterization and Urgent Intervention Triage Strategy Trial Circulation 121 2009 43 51
6. S.V. Manoukian, F. Feit, and R. Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial J Am Coll Cardiol 49 2007 1362 1368 (Pubitemid 46476844)
7. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)
8. D.W. Park, S.C. Yun, and S.W. Lee Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents J Am Coll Cardiol Interv 1 2008 494 503
9. S.C. Smith Jr., T.E. Feldman, and J.W. Hirshfeld Jr., American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention J Am Coll Cardiol 47 2006 e1 e121
10. S.W. Lee, S.W. Park, and M.K. Hong Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis J Am Coll Cardiol 46 2005 1833 1837
11. G. Montalescot, H.D. White, and R. Gallo Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention N Engl J Med 355 2006 1006 1017 (Pubitemid 44343544)
12. D.G. Altman, and B.L. De Stavola Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates Stat Med 13 1994 301 341 (Pubitemid 24048573)
13. S.R. Steinhubl, P.B. Berger, and J.T. Mann-Iii Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
14. A.K. Rao, C. Pratt, and A. Berke Thrombolysis in Myocardial Infarction (TIMI) Trialphase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11 (Pubitemid 18029027)
15. The GUSTO investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
16. R. Waksman Definition, incidence, correlates, and clinical impact of "Nuisance" bleeding in patients undergoing drug-eluting stent implantation Am J Cardiol 104 Suppl 1 2009 30C3C
17. S.V. Rao, J. Eikelboom, and P.G. Steg Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group Am Heart J 158 2009 881 886
18. S.V. Manoukian Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction Am J Cardiol 104 Suppl 1 2009 9C 15C
19. T.Y. Wang, L. Xiao, and K.P. Alexander Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding Circulation 118 2008 2139 2145
20. M.J. Ricciardi, E. Wu, and C.J. Davidson Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation Circulation 103 2001 2780 2783 (Pubitemid 32550063)
21. S.J. Brener, B.W. Lytle, J.P. Schneider, S.G. Ellis, and E.J. Topol Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality J Am Coll Cardiol 40 2002 1961 1967 (Pubitemid 35428831)
22. D.T. Ko, L. Yun, and H.C. Wijeysundera Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years Circ Cardiovasc Interv 3 2010 140 147
23. T.H. Wang, D.L. Bhatt, and K.A.A. Fox An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial Eur Heart J 28 2007 2200 2207 (Pubitemid 47428941)
24. P.H.-C. Diener, P.J. Bogousslavsky, and P.L.M. Brass Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial Lancet 364 2004 331 337 (Pubitemid 38970009)
25. S.J. Park, D.W. Park, and Y.H. Kim Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382